Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

EXAS

Exact Sciences Corp.

Oct 03 • 12:48PM ET

67.03

Dollar change +0.12
Percentage change 0.19	%

Healthcare • Diagnostics & Research • USA • NASD

Held by: VTI VB XBI VXF VBK FBT IWR VHT SCHM IWP

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.96	Insider Own	1.51%	Shs Outstand	184.77M	Perf Week	-1.35%
Market Cap	12.38B	Forward P/E	477.76	EPS next Y	0.14	Insider Trans	-0.20%	Shs Float	181.98M	Perf Month	17.32%
Income	-175.01M	PEG	-	EPS next Q	-0.19	Inst Own	97.29%	Short Float	9.02%	Perf Quarter	50.38%
Sales	2.61B	P/S	4.74	EPS this Y	17.61%	Inst Trans	-1.71%	Short Ratio	6.25	Perf Half Y	-4.47%
Book/sh	17.29	P/B	3.88	EPS next Y	115.07%	ROA	-2.69%	Short Interest	16.42M	Perf Year	2.17%
Cash/sh	5.12	P/C	13.08	EPS next 5Y	-	ROE	-5.60%	52W Range	40.62 - 79.62	Perf YTD	-9.40%
Dividend Est.	-	P/FCF	-	EPS past 5Y	4.59%	ROI	-3.07%	52W High	-15.82%	Beta	1.28
Dividend TTM	-	Quick Ratio	1.98	Sales past 5Y	43.88%	Gross Margin	69.63%	52W Low	64.99%	ATR (14)	2.63
Dividend Ex-Date	-	Current Ratio	2.17	EPS Y/Y TTM	60.38%	Oper. Margin	-10.76%	RSI (14)	56.05	Volatility	3.80% 4.59%
Employees	6600	Debt/Eq	0.87	Sales Y/Y TTM	13.54%	Profit Margin	-6.70%	Recom	1.36	Target Price	78.52
Option/Short	Yes / Yes	LT Debt/Eq	0.78	EPS Q/Q	80.92%	Payout	-	Rel Volume	0.26	Prev Close	66.90
Sales Surprise	1.34%	EPS Surprise	73.55%	Sales Q/Q	12.41%	Earnings	Jul 31 AMC	Avg Volume	2.63M	Price	67.03
SMA20	1.17%	SMA50	11.35%	SMA200	13.75%	Trades		Volume	359,448	Change	0.19%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-28-24	Initiated	Wells Fargo	Overweight	$75
Jun-27-24	Initiated	Scotiabank	Sector Outperform	$70
Jun-03-24	Resumed	Jefferies	Buy	$75
Jan-02-24	Upgrade	The Benchmark Company	Hold → Buy	$91
Dec-14-23	Initiated	Guggenheim	Buy	$90
Dec-13-23	Initiated	Wolfe Research	Outperform	$95
Oct-10-23	Upgrade	Piper Sandler	Neutral → Overweight	$90
Sep-28-23	Initiated	Bernstein	Outperform	$83
Aug-02-23	Downgrade	The Benchmark Company	Buy → Hold
May-10-23	Upgrade	Craig Hallum	Hold → Buy	$55 → $85
May-05-23	Initiated	UBS	Neutral	$73
Mar-09-23	Upgrade	Citigroup	Neutral → Buy	$70 → $90
Feb-10-23	Downgrade	Credit Suisse	Outperform → Neutral	$50 → $70
Jan-18-23	Downgrade	Raymond James	Outperform → Mkt Perform
Oct-19-22	Downgrade	Craig Hallum	Buy → Hold	$60 → $35
Aug-25-22	Initiated	Credit Suisse	Outperform	$55
Jun-03-22	Initiated	Piper Sandler	Neutral	$50
Nov-03-21	Downgrade	Raymond James	Strong Buy → Outperform	$160 → $130
Jul-29-21	Reiterated	Stifel	Buy	$165 → $145
Jul-29-21	Reiterated	Oppenheimer	Outperform	$161 → $155

Show Previous Ratings

Sep-18-24 06:03PM	Analyst Report: Exact Sciences Corporation (Morningstar Research)
Sep-17-24 07:00AM	The Battle Brewing Over Blood Tests for Cancer (The Wall Street Journal)
Sep-16-24 07:55AM	Exact Sciences says data support its colon cancer blood test (MedTech Dive) +6.01%
07:53AM	ESMO 2024: Exact Sciences unveils results from cancer algorithm trial (Medical Device Network)
02:35AM	Exact Sciences Presents Data Demonstrating Advancement in Blood-based Colorectal Cancer Screening at ESMO 2024 (Business Wire)
07:28PM	Loading…
Sep-12-24 07:28PM	Analyst Report: Exact Sciences Corporation (Morningstar Research) +5.10%
Sep-11-24 07:18AM	Should You Hold Exact Sciences Corporation (EXAS)? (Insider Monkey) +9.83%
Sep-09-24 09:55AM	Wall Street Analysts Believe Exact Sciences (EXAS) Could Rally 34.33%: Here's is How to Trade (Zacks)
Aug-30-24 11:31AM	Exact Sciences (EXAS) Up 7.5% Since Last Earnings Report: Can It Continue? (Zacks)
Aug-28-24 06:00AM	Exact Sciences to Participate in September Investor Conferences (Business Wire)
Aug-23-24 08:26AM	Should You Believe in the Growth Potential of Exact Sciences Corporation (EXAS)? (Insider Monkey)
06:00AM	Sector Spotlight: Top 4 Basket of Diagnostic Stocks (EXAS, GH, ILMN, LUDG) (News Direct)
Aug-22-24 09:55AM	Does Exact Sciences (EXAS) Have the Potential to Rally 34.13% as Wall Street Analysts Expect? (Zacks)
09:23AM	Exact Sciences (EXAS) Rides on Cologuard Sales, New Launches (Zacks)
08:41AM	Exact Sciences (EXAS) Enrolls First Patient in Pivotal MCED Study (Zacks)
11:08PM	Loading…
Aug-21-24 11:08PM	Atlassian Corporation (TEAM): Short Sellers Are Bullish On This Advertising Stock Now (Insider Monkey)
08:08AM	Heres Why Baron Opportunity Fund Sold its Stake in Exact Sciences Corp (EXAS) (Insider Monkey)
07:13AM	Exact Sciences kicks off multi-cancer detection study (Medical Device Network)
Aug-20-24 07:00AM	Exact Sciences Announces First Patient Enrolled in its Multi-Cancer Early Detection (MCED) Falcon Registry Real-World Evidence Study (Business Wire)
Aug-16-24 07:13AM	Exact Sciences data finds Cologuard detected almost 600k cancer cases (Medical Device Network)
Aug-15-24 07:00AM	New Modeling Data Show the Cologuard Test Has Detected More Than 623,000 Cancers and Precancers Over Past Decade, Saving U.S. Health Care System $22 Billion (Business Wire)
Aug-14-24 09:19AM	Why You Should Add Exact Sciences (EXAS) to Your Portfolio (Zacks)
Aug-11-24 02:47PM	Atlassian Corporation (TEAM): Hedge Funds Are Bullish on This AdTech Stock Now (Insider Monkey)
Aug-10-24 09:22PM	8 Best AdTech Stocks to Buy Now (Insider Monkey)
Aug-06-24 09:55AM	Wall Street Analysts Predict a 45.04% Upside in Exact Sciences (EXAS): Here's What You Should Know (Zacks)
Aug-02-24 01:08AM	Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight (GuruFocus.com)
Aug-01-24 04:02PM	Why Exact Sciences, Up 27%, Is 'Coiled To Snap Back' After Quarterly Beat (Investor's Business Daily) +26.77%
10:49AM	Analyst Report: Exact Sciences Corporation (Morningstar Research)
09:03AM	Exact Sciences (EXAS) Q2 Loss Narrower Than Expected, Sales Beat (Zacks)
12:00AM	Exact Sciences (EXAS) Q2 2024 Earnings Call Transcript (Motley Fool)
07:30PM	Loading…
Jul-31-24 07:30PM	Exact Sciences (EXAS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
06:28PM	Exact Sciences: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	TwinStrand Biosciences and Exact Sciences Announce Exclusive License Agreement for Duplex Sequencing Technology (PR Newswire)
04:05PM	Exact Sciences Announces Second-Quarter 2024 Results (Business Wire)
Jul-24-24 10:01AM	Exact Sciences (EXAS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Jul-22-24 09:32AM	Goldman Sachs Says Buy These 3 Stocks for Double-Digit Returns (InvestorPlace)
Jul-16-24 06:06AM	Lattice Semiconductor Corporation (LSCC) Slipped Due to Cyclical Pressures (Insider Monkey) +5.57%
05:57AM	Exact Sciences Corporation (EXAS) Slipped Over Investors' Concerns (Insider Monkey)
05:53AM	Should You Believe in the Upside Potential of Celsius Holdings (CELH)? (Insider Monkey)
Jul-11-24 06:33AM	Geneoscopys ColoSense deemed reliable in published study (Medical Device Network)
Jul-08-24 08:30AM	This Cathie Wood Growth Stock Could Soar by 93%, According to Wall Street (Motley Fool)
06:00AM	Exact Sciences schedules second quarter 2024 earnings call (Business Wire)
Jul-07-24 05:30AM	People Are Feeling Stuck in Their Jobs. Bosses Are Starting to Worry. (The Wall Street Journal)
Jul-03-24 07:00AM	The 3 Best Personalized Medicine Stocks to Buy in July 2024 (InvestorPlace)
Jun-20-24 10:13AM	NGS: the road to personalising cancer care (Medical Device Network)
Jun-17-24 12:54PM	MGI and SeqOne partner to create end-to-end genomic testing platform (Medical Device Network)
Jun-13-24 10:12AM	Jefferies Says Buy These 3 Stocks for More Than Double-Digit Returns (InvestorPlace)
06:45AM	Is It Time to Buy May's Worst-Performing Nasdaq Stocks? (Motley Fool)
Jun-07-24 11:30AM	Why Is Exact Sciences (EXAS) Down 17.5% Since Last Earnings Report? (Zacks)
Jun-04-24 07:06AM	Illumina names Everett Cunningham as chief commercial officer (MedTech Dive)
Jun-03-24 04:26PM	Is Exact Sciences Corporation (NASDAQ:EXAS) the Gene Therapy Stock with the Greatest Potential? (Insider Monkey)
04:17PM	9 Best Gene Therapy Stocks to Buy Now (Insider Monkey)
May-30-24 06:35AM	10 Buzzing AI Semiconductor Stocks in 2024 (Insider Monkey)
May-29-24 11:27AM	Exact Sciences (EXAS) Witnesses Rising Expenses, Competition (Zacks)
May-28-24 10:34AM	Exact Sciences (EXAS) to Showcase Favorable Research Outcome (Zacks) -5.66%
06:00AM	Exact Sciences to Participate in June Investor Conferences (Business Wire)
May-27-24 06:43PM	Hedge Funds are Bullish on This Cancer Stock (Insider Monkey)
06:13PM	7 Best Mid-Cap Healthcare Stocks To Buy Now (Insider Monkey)
11:34AM	Bull Market Blastoff: 3 Stocks Targeting 56% to 91% Returns (InvestorPlace)
May-24-24 10:28AM	Guardant Stock Climbs As Cancer Test Strides Towards FDA Ok (The Wall Street Journal) -7.84%
07:11AM	FDA panel backs Guardants blood test for colon cancer (MedTech Dive)
06:05AM	Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO (Business Wire)
May-22-24 07:30AM	Exact Sciences Earns 2024 Great Place To Work Certification (Business Wire)
May-21-24 08:56AM	Exact Sciences Says Court Allows Patent Lawsuit Against Geneoscopy to Proceed (MT Newswires)
06:05AM	Court Ruling Enables Exact Sciences to Proceed with Lawsuit against Geneoscopy (Business Wire)
May-17-24 06:27AM	Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024 (InvestorPlace)
May-10-24 12:27PM	Exact Sciences Corp (EXAS) Q1 2024 Earnings: Revenue Growth Amidst Increased Net Loss (GuruFocus.com)
09:22AM	UK NICE backs Exacts Oncotype cancer genomic test (Medical Device Network)
May-09-24 04:02PM	Exact Sciences Stock, A Cathie Wood Darling, Tumbles On 'Overblown' Growth Concerns (Investor's Business Daily) -8.96%
12:29PM	Analyst Report: Exact Sciences Corporation (Morningstar Research)
11:41AM	Exact Sciences Corporation (NASDAQ:EXAS) Q1 2024 Earnings Call Transcript (Insider Monkey)
11:02AM	Exact Sciences (EXAS) Q1 Revenues Rise Y/Y, Gross Margin Down (Zacks)
09:59AM	Q1 2024 Exact Sciences Corp Earnings Call (Thomson Reuters StreetEvents)
07:29AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace)
03:53AM	Exact Sciences Corp (EXAS) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth ... (GuruFocus.com)
01:06AM	Decoding Exact Sciences Corp (EXAS): A Strategic SWOT Insight (GuruFocus.com)
May-08-24 11:30PM	Exact Sciences (EXAS) Q1 2024 Earnings Call Transcript (Motley Fool)
06:05PM	Exact Sciences (EXAS) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:02PM	Exact Sciences: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Exact Sciences Announces First-Quarter 2024 Results (Business Wire)
May-07-24 08:00AM	Exact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW 2024 (Business Wire)
May-06-24 08:52AM	MDxHealth SA (NASDAQ:MDXH) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-01-24 06:00AM	Exact Sciences to Participate in May Investor Conference (Business Wire)
Apr-25-24 08:05PM	Analyst Report: Exact Sciences Corporation (Morningstar Research) -7.04%
Apr-24-24 06:15PM	Exact Sciences (EXAS) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
07:16AM	Here's Why Baron Health Care Fund Reduced Exact Sciences Corporation (EXAS) (Insider Monkey)
Apr-22-24 12:44PM	Should You Buy Exact Sciences (EXAS) Ahead of Q1 Earnings? (Zacks)
11:10AM	10 Best Performing Biotech ETFs in 2024 (Insider Monkey)
Apr-17-24 06:15PM	Why Exact Sciences (EXAS) Dipped More Than Broader Market Today (Zacks)
Apr-15-24 06:52AM	Exact Sciences names Aaron Bloomer CFO (MedTech Dive) -8.40%
06:00AM	Exact Sciences Names Aaron Bloomer as New Chief Financial Officer (Business Wire)
Apr-12-24 07:00AM	Here's Why Exact Sciences Corporation (EXAS) Declined in Q1 (Insider Monkey)
06:49AM	Should You Hold ON Semiconductor Corporation (ON)? (Insider Monkey)
06:40AM	Should You be Bullish on the Long-Term Growth of Atlassian Corporation (TEAM)? (Insider Monkey)
Apr-11-24 06:00AM	Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes (Business Wire)
Apr-10-24 06:15PM	Exact Sciences (EXAS) Stock Moves -0.89%: What You Should Know (Zacks)
08:16AM	Search for Cancer Blood Test Continues Despite Illumina-Grail Deals Failure (Barrons.com)
12:00AM	ZTS, EXAS, AZN: Which Biotech Stock Is the Better Buy? (TipRanks)
Apr-09-24 07:37AM	11 Best Biotech ETFs To Buy (Insider Monkey)
Apr-08-24 12:05PM	Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024 (Business Wire)

EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Baranick Brian	EVP, GM, Precision Oncology	Sep 18 '24	Sale	70.00	929	65,030	13,687	Sep 19 05:00 PM
Baranick Brian	Officer	Sep 18 '24	Proposed Sale	70.00	929	65,030		Sep 18 04:15 PM
Baranick Brian	EVP, GM, Precision Oncology	Aug 05 '24	Option Exercise	0.00	2,712	0	15,991	Aug 06 05:30 PM
COWARD D SCOTT	Director	May 01 '24	Sale	60.15	67	4,030	44,644	May 02 07:00 PM
Cunningham Everett	Chief Commercial Officer	May 01 '24	Sale	60.15	136	8,180	47,042	May 02 07:00 PM
Herriott James	SVP, General Counsel & Sec	May 01 '24	Sale	60.15	30	1,804	9,866	May 02 07:00 PM
Elliott Jeffrey Thomas	Chief Financial Officer	May 01 '24	Sale	60.15	136	8,180	11,795	May 02 07:00 PM
Baranick Brian	EVP, GM., Precision Oncology	May 01 '24	Sale	60.15	110	6,616	13,279	May 02 07:00 PM
Condella Sarah	EVP, Human Resources	May 01 '24	Sale	60.15	102	6,135	72,611	May 02 07:00 PM
ORVILLE JACOB A	General Manager, Screening	May 01 '24	Sale	60.15	102	6,135	14,440	May 02 07:00 PM
Conroy Kevin T	President and CEO	May 01 '24	Sale	60.15	1,155	69,473	1,156,191	May 02 07:00 PM
Condella Sarah	EVP, Human Resources	Apr 01 '24	Sale	70.00	2,000	140,000	71,787	Apr 03 07:30 PM
Baranick Brian	EVP, GM., Precision Oncology	Apr 02 '24	Sale	79.43	924	73,393	13,171	Apr 03 07:30 PM
Condella Sarah	EVP, Human Resources	Mar 28 '24	Sale	70.00	2,000	140,000	73,787	Apr 01 04:30 PM
ORVILLE JACOB A	General Manager, Screening	Feb 29 '24	Option Exercise	0.00	4,724	0	16,478	Mar 04 08:42 PM
ORVILLE JACOB A	General Manager, Screening	Mar 01 '24	Sale	59.32	2,154	127,775	14,324	Mar 04 08:42 PM
LEVANGIE DANIEL J	Director	Mar 01 '24	Sale	57.50	5,000	287,500	22,975	Mar 04 08:42 PM
Herriott James	General Counsel	Feb 29 '24	Option Exercise	0.00	1,890	0	9,987	Mar 04 08:41 PM
Herriott James	General Counsel	Mar 01 '24	Sale	59.32	862	51,134	9,125	Mar 04 08:41 PM
Elliott Jeffrey Thomas	Chief Financial Officer	Feb 29 '24	Option Exercise	0.00	5,291	0	13,345	Mar 04 08:40 PM
Elliott Jeffrey Thomas	Chief Financial Officer	Mar 01 '24	Sale	59.32	2,412	143,080	10,933	Mar 04 08:40 PM
Doyle James Edward	Director	Mar 01 '24	Sale	57.50	2,000	115,000	50,110	Mar 04 08:39 PM
Cunningham Everett	Chief Commercial Officer	Feb 29 '24	Option Exercise	0.00	5,291	0	48,591	Mar 04 08:38 PM
Cunningham Everett	Chief Commercial Officer	Mar 01 '24	Sale	59.32	2,412	143,080	46,179	Mar 04 08:38 PM
Conroy Kevin T	President and CEO	Feb 29 '24	Option Exercise	0.00	18,143	0	1,307,767	Mar 04 08:38 PM
Conroy Kevin T	President and CEO	Mar 01 '24	Sale	59.32	8,271	490,636	1,299,496	Mar 04 08:38 PM
Condella Sarah	EVP, Human Resources	Feb 29 '24	Option Exercise	0.00	3,779	0	77,511	Mar 04 08:37 PM
Condella Sarah	EVP, Human Resources	Mar 01 '24	Sale	59.32	1,724	102,268	75,787	Mar 04 08:37 PM
Baranick Brian	Gen. Mgr., Precision Oncology	Feb 29 '24	Option Exercise	0.00	4,724	0	16,418	Mar 04 08:36 PM
Baranick Brian	Gen. Mgr., Precision Oncology	Mar 01 '24	Sale	59.32	2,323	137,800	14,095	Mar 04 08:36 PM
ORVILLE JACOB A	General Manager, Screening	Feb 26 '24	Option Exercise	0.00	3,954	0	13,633	Feb 28 07:38 PM
ORVILLE JACOB A	General Manager, Screening	Feb 27 '24	Sale	56.89	1,879	106,896	11,754	Feb 28 07:38 PM
Herriott James	General Counsel	Feb 26 '24	Option Exercise	0.00	1,648	0	8,881	Feb 28 07:38 PM
Herriott James	General Counsel	Feb 27 '24	Sale	56.89	784	44,602	8,097	Feb 28 07:38 PM
Cunningham Everett	Chief Commercial Officer	Feb 26 '24	Option Exercise	0.00	7,678	0	46,948	Feb 28 07:37 PM
Cunningham Everett	Chief Commercial Officer	Feb 27 '24	Sale	56.89	3,648	207,535	43,300	Feb 28 07:37 PM
Elliott Jeffrey Thomas	Chief Financial Officer	Feb 26 '24	Option Exercise	0.00	5,701	0	10,764	Feb 28 07:36 PM
Elliott Jeffrey Thomas	Chief Financial Officer	Feb 27 '24	Sale	56.89	2,710	154,172	8,054	Feb 28 07:36 PM
Conroy Kevin T	President and CEO	Feb 26 '24	Option Exercise	0.00	13,181	0	1,295,887	Feb 28 07:35 PM
Conroy Kevin T	President and CEO	Feb 27 '24	Sale	56.89	6,263	356,302	1,289,624	Feb 28 07:35 PM
Condella Sarah	EVP, Human Resources	Feb 26 '24	Option Exercise	0.00	3,954	0	75,612	Feb 28 07:35 PM
Condella Sarah	EVP, Human Resources	Feb 27 '24	Sale	56.89	1,880	106,953	73,732	Feb 28 07:35 PM
Baranick Brian	Gen. Mgr., Precision Oncology	Feb 26 '24	Option Exercise	0.00	3,954	0	13,721	Feb 28 07:34 PM
Baranick Brian	Gen. Mgr., Precision Oncology	Feb 27 '24	Sale	56.89	2,027	115,316	11,694	Feb 28 07:34 PM
Conroy Kevin T	President and CEO	Feb 23 '24	Option Exercise	13.96	102,837	1,435,605	1,344,266	Feb 26 05:00 PM
Condella Sarah	EVP, Human Resources	Feb 23 '24	Sale	59.72	1,021	60,974	71,658	Feb 26 05:00 PM
ORVILLE JACOB A	General Manager, Screening	Feb 22 '24	Sale	59.78	1,013	60,557	9,679	Feb 23 08:03 PM
Herriott James	General Counsel	Feb 22 '24	Sale	59.78	291	17,396	7,233	Feb 23 08:02 PM
Elliott Jeffrey Thomas	Chief Financial Officer	Feb 22 '24	Sale	59.78	1,351	80,763	5,063	Feb 23 08:01 PM
Cunningham Everett	Chief Commercial Officer	Feb 22 '24	Sale	59.78	1,350	80,703	39,270	Feb 23 08:00 PM
COWARD D SCOTT	Director	Feb 22 '24	Sale	59.78	663	39,634	44,493	Feb 23 07:59 PM
Conroy Kevin T	President and CEO	Feb 22 '24	Sale	59.78	11,565	691,356	1,241,429	Feb 23 07:59 PM
Condella Sarah	EVP, Human Resources	Feb 22 '24	Sale	59.78	1,013	60,557	72,679	Feb 23 07:57 PM
Baranick Brian	Gen. Mgr., Precision Oncology	Feb 22 '24	Sale	59.78	1,093	65,340	9,767	Feb 23 07:57 PM
ORVILLE JACOB A	General Manager, Screening	Feb 20 '24	Option Exercise	0.00	2,248	0	9,736	Feb 22 07:40 PM
ORVILLE JACOB A	General Manager, Screening	Feb 21 '24	Sale	61.50	1,078	66,297	8,658	Feb 22 07:40 PM
Herriott James	General Counsel	Feb 20 '24	Option Exercise	0.00	864	0	7,358	Feb 22 07:39 PM
Herriott James	General Counsel	Feb 21 '24	Sale	61.50	415	25,522	6,943	Feb 22 07:39 PM
Elliott Jeffrey Thomas	Chief Financial Officer	Feb 20 '24	Option Exercise	0.00	3,112	0	5,196	Feb 22 07:38 PM
Elliott Jeffrey Thomas	Chief Financial Officer	Feb 21 '24	Sale	61.50	1,493	91,820	3,703	Feb 22 07:38 PM
COWARD D SCOTT	Director	Feb 20 '24	Option Exercise	0.00	2,248	0	43,828	Feb 22 07:38 PM
COWARD D SCOTT	Director	Feb 21 '24	Sale	61.50	706	43,419	43,122	Feb 22 07:38 PM
Conroy Kevin T	President and CEO	Feb 20 '24	Option Exercise	0.00	10,374	0	1,234,731	Feb 22 07:37 PM
Conroy Kevin T	President and CEO	Feb 21 '24	Sale	61.50	4,975	305,962	1,229,756	Feb 22 07:37 PM
Condella Sarah	EVP, Human Resources	Feb 20 '24	Option Exercise	0.00	2,248	0	72,737	Feb 22 07:36 PM
Condella Sarah	EVP, Human Resources	Feb 21 '24	Sale	61.50	1,079	66,358	71,658	Feb 22 07:36 PM
Baranick Brian	Gen. Mgr., Precision Oncology	Feb 20 '24	Option Exercise	0.00	1,729	0	9,721	Feb 22 07:36 PM
Baranick Brian	Gen. Mgr., Precision Oncology	Feb 21 '24	Sale	61.50	895	55,042	8,826	Feb 22 07:36 PM
ORVILLE JACOB A	General Manager, Screening	Feb 14 '24	Option Exercise	0.00	2,031	0	8,454	Feb 16 06:26 PM
ORVILLE JACOB A	General Manager, Screening	Feb 15 '24	Sale	61.43	966	59,341	7,488	Feb 16 06:26 PM
Herriott James	General Counsel	Feb 14 '24	Option Exercise	0.00	883	0	6,915	Feb 16 06:25 PM
Herriott James	General Counsel	Feb 15 '24	Sale	61.43	421	25,862	6,494	Feb 16 06:25 PM
Elliott Jeffrey Thomas	Chief Financial Officer	Feb 14 '24	Option Exercise	0.00	3,972	0	3,972	Feb 16 06:24 PM
Elliott Jeffrey Thomas	Chief Financial Officer	Feb 15 '24	Sale	61.43	1,888	115,980	2,084	Feb 16 06:24 PM
COWARD D SCOTT	Director	Feb 14 '24	Option Exercise	0.00	3,972	0	42,956	Feb 16 06:23 PM
COWARD D SCOTT	Director	Feb 15 '24	Sale	61.43	1,376	84,528	41,580	Feb 16 06:23 PM
Conroy Kevin T	President and CEO	Feb 14 '24	Option Exercise	0.00	31,133	0	1,239,148	Feb 16 06:22 PM
Conroy Kevin T	President and CEO	Feb 15 '24	Sale	61.43	14,791	908,611	1,224,357	Feb 16 06:22 PM
Condella Sarah	EVP, Human Resources	Feb 14 '24	Option Exercise	0.00	2,031	0	71,454	Feb 16 06:21 PM
Condella Sarah	EVP, Human Resources	Feb 15 '24	Sale	61.43	965	59,280	70,489	Feb 16 06:21 PM
Condella Sarah	EVP, Human Resources	Jan 02 '24	Sale	73.50	2,000	147,000	69,423	Jan 04 05:19 PM
Baranick Brian	Gen. Mgr., Precision Oncology	Jan 02 '24	Sale	73.50	879	64,606	7,992	Jan 04 05:17 PM
Condella Sarah	EVP, Human Resources	Dec 14 '23	Sale	70.00	2,000	140,000	71,423	Dec 18 07:49 PM
Cunningham Everett	Chief Commercial Officer	Oct 11 '23	Option Exercise	0.00	27,504	0	50,916	Oct 13 07:59 PM
Cunningham Everett	Chief Commercial Officer	Oct 12 '23	Sale	66.49	13,007	864,835	37,909	Oct 13 07:59 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

EXAS

Exact Sciences Corp.

Upgrade your FINVIZ experience